U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H21N5O3S
Molecular Weight 399.467
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OXMETIDINE

SMILES

CC1=C(CSCCNC2=NC=C(CC3=CC=C4OCOC4=C3)C(=O)N2)N=CN1

InChI

InChIKey=YTBDPHYVGACIPC-UHFFFAOYSA-N
InChI=1S/C19H21N5O3S/c1-12-15(23-10-22-12)9-28-5-4-20-19-21-8-14(18(25)24-19)6-13-2-3-16-17(7-13)27-11-26-16/h2-3,7-8,10H,4-6,9,11H2,1H3,(H,22,23)(H2,20,21,24,25)

HIDE SMILES / InChI

Molecular Formula C19H21N5O3S
Molecular Weight 399.467
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Oxmetidine is an H2-receptor antagonist that was studied as a gastrointestinal agent. Oxmetidine possesses efficacy in the treatment of peptic ulcers. However, information about the further development of this drug is not available.

Approval Year

PubMed

Sample Use Guides

In Vitro Use Guide
Oxmetidine (50 microM) blocked pyruvate/malate-supported state 3 (ADP-stimulated) respiration, caused a decrease in the ADP:0 ratio and a loss of respiratory control in isolated rat liver mitochondria.
Substance Class Chemical
Record UNII
Z504D030RF
Record Status Validated (UNII)
Record Version